Felimazole 1.25 mg 1.25 mg Tablet is a Health Canada–registered veterinary drug (DIN 02411512) held by Dechra Ltd, containing Methimazole. Health Canada lists its status as Marketed (status date 23 Jan 2014). Nexara Health has matched 210 registrations of Methimazole across 24 other regulated markets, 2 of them in the same strength and dosage form.

Health Canada registration

Methimazole registered in other markets

210 registrations of the same molecule in 24 national registries outside Canada (first 83 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Methimazole worldwide →

Regulator price references for Methimazole

Published list or reimbursement prices for Methimazole presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Marketed Canadian products with the same active ingredient

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Felimazole 1.25 mg (DIN 02411512) marketed in Canada?

Yes. Health Canada lists DIN 02411512 as Marketed as of 23 Jan 2014.

Who holds the Canadian licence for this product?

Dechra Ltd is the company of record in the Health Canada Drug Product Database.

Is Methimazole registered outside Canada?

Yes — Nexara Health has matched 210 registrations in 24 other markets, including 2 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02411512, status date 2014-01-23; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, CBZ, CMED, CNS liste positive, CSG Compendio (formulary), DH Drug Office, eEKO (Erstattungskodex), EU national register, FDA NDC, HSA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, MZ SR kategorizacia, NHS dm+d VMP, SUKL DLP, TFDA, TITCK, TLV periodens varor, URPL RPL; price sources: CMED, CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, TLV periodens varor. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02411512, status date 2014-01-23; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, CBZ, CMED, CNS liste positive, CSG Compendio (formulary), DH Drug Office, eEKO (Erstattungskodex), EU national register, FDA NDC, HSA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, MZ SR kategorizacia, NHS dm+d VMP, SUKL DLP, TFDA, TITCK, TLV periodens varor, URPL RPL; price sources: CMED, CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, TLV periodens varor.

Health Canada Drug Product Database (DPD), DIN 02411512, status date 2014-01-23; national medicine registries: ALIMS, ANMDMR nomenclator, BDA, CBZ, CMED, CNS liste positive, CSG Compendio (formulary), DH Drug Office, eEKO (Erstattungskodex), EU national register, FDA NDC, HSA, HZZO, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, MZ SR kategorizacia, NHS dm+d VMP, SUKL DLP, TFDA, TITCK, TLV periodens varor, URPL RPL; price sources: CMED, CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, MZ SR kategorizacia, TLV periodens varor. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.